Literature DB >> 6314239

The active guanidinium group of saxitoxin and neosaxitoxin identified by the effects of pH on their activities on squid axon.

P N Kao, M R James-Kracke, C Y Kao.   

Abstract

The relative potencies of saxitoxin at pH 7.25 and 8.25 have been determined on the squid giant axon under voltage-clamp conditions or by Vmax of the propagated action potential. Of the two guanidinium groups in saxitoxin, the 7, 8, 9 group has been identified as the biologically active group. The evidence lies in the demonstration of a quantitative agreement between the relative abundance of the protonated, positively charged form of that group at pH's 7.25 and 8.25 (ratio 1.80) with the relative potencies (ratio 1.79) of the toxin. The 1, 2, 3 group is excluded by the lack of agreement between the relative abundance of the protonated form (ratio 1.00) and the relative potencies at these pH's. The 1, 2, 3 group is further excluded by the observation that neosaxitoxin is equally potent at pH 6.50 and 7.25, in spite of a difference of 6-fold in the abundance of a deprotonated hydroxyl group on N-1 which should have influenced the potency.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6314239     DOI: 10.1007/bf00657151

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  24 in total

1.  The receptor for tetrodotoxin and saxitoxin. A structural hypothesis.

Authors:  B Hille
Journal:  Biophys J       Date:  1975-06       Impact factor: 4.033

2.  TARICHATOXIN--TETRODOTOXIN: A POTENT NEUROTOXIN.

Authors:  H S MOSHER; F A FUHRMAN; H D BUCHWALD; H G FISCHER
Journal:  Science       Date:  1964-05-29       Impact factor: 47.728

3.  A biologically active acid hydrolysis product of saxitoxin.

Authors:  V E Ghazarossian; E J Schantz; H K Schnoes; F M Strong
Journal:  Biochem Biophys Res Commun       Date:  1976-02-09       Impact factor: 3.575

4.  The influence of pH on equilibrium effects of tetrodotoxin on myelinated nerve fibres of Rana esculenta.

Authors:  W Ulbricht; H H Wagner
Journal:  J Physiol       Date:  1975-10       Impact factor: 5.182

5.  Dependence of tetrodotoxin blockage of nerve membrane conductance on external pH.

Authors:  T Narahashi; J W Moore; D T Frazier
Journal:  J Pharmacol Exp Ther       Date:  1969-10       Impact factor: 4.030

6.  Actions of saxitoxin on peripheral neuromuscular systems.

Authors:  C Y Kao; A Nishiyama
Journal:  J Physiol       Date:  1965-09       Impact factor: 5.182

7.  Equilibrium and kinetic properties of the interaction between tetrodotoxin and the excitable membrane of the squid giant axon.

Authors:  L A Cuervo; W J Adelman
Journal:  J Gen Physiol       Date:  1970-03       Impact factor: 4.086

8.  Saxitoxin and tetrodotoxin: comparison of nerve blocking mechanism.

Authors:  T Narahashi; H G Haas; E F Therrien
Journal:  Science       Date:  1967-09-22       Impact factor: 47.728

9.  Tetrodotoxin. VII. On the structure of tetrodotoxin and its derivatives.

Authors:  K Tsuda; S Ikuma; M Kawamura; R Tachikawa; K Sakai
Journal:  Chem Pharm Bull (Tokyo)       Date:  1964-11       Impact factor: 1.645

10.  The rate of action of tetrodotoxin on myelinated nerve fibres of Xenopus laevis and Rana esculenta.

Authors:  J R Schwarz; W Ulbricht; H H Wagner
Journal:  J Physiol       Date:  1973-08       Impact factor: 5.182

View more
  3 in total

1.  Interactions of neosaxitoxin with the sodium channel of the frog skeletal muscle fiber.

Authors:  S L Hu; C Y Kao
Journal:  J Gen Physiol       Date:  1991-03       Impact factor: 4.086

2.  Specific neosaxitoxin interactions with the Na+ channel outer vestibule determined by mutant cycle analysis.

Authors:  J L Penzotti; G Lipkind; H A Fozzard; S C Dudley
Journal:  Biophys J       Date:  2001-02       Impact factor: 4.033

3.  Voltage-dependent blockade of muscle Na+ channels by guanidinium toxins.

Authors:  E Moczydlowski; S Hall; S S Garber; G S Strichartz; C Miller
Journal:  J Gen Physiol       Date:  1984-11       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.